-
Mashup Score: 1SBRT shows tolerability in high-risk and recurrent prostate cancer - 1 month(s) ago
Treatment with SBRT showed a minimal effect on prostate cancer-specific HRQL measures in regard to urinary incontinence domain scores, urinary irritative/obstructive domain scores, and bowel domain scores.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
Treatment with SBRT demonstrated favorable quality of life outcomes in patients with high-risk and locally recurrent prostate cancer. @the_RSS #2024rss #pcsm #urology Read more: https://t.co/Z9pjeVK5Hg